3-O-METHYLDOPA AND THE RESPONSE TO LEVODOPA IN PARKINSONS-DISEASE

被引：120
作者：
NUTT, JG
WOODWARD, WR
GANCHER, ST
MERRICK, D
机构：
来源：
ANNALS OF NEUROLOGY | 1987年 / 21卷 / 06期
关键词：
D O I：
10.1002/ana.410210610
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：584 / 588
页数：5
相关论文
共 50 条
[21]   DEMETHYLATION OF 3-O-METHYLDOPA [J].
CHALMERS, JP ;
DAVIS, DS ;
DRAFFAN, GH ;
REID, JL ;
THORGEIRSSON, SS .
BRITISH JOURNAL OF PHARMACOLOGY, 1971, 43 (02) :P455-+
[22]   MESULERGINE AND LEVODOPA IN PARKINSONS-DISEASE [J].
TERAVAINEN, H ;
HIETANEN, M ;
HUTTUNEN, J ;
PIHL, S .
ACTA NEUROLOGICA SCANDINAVICA, 1984, 69 :51-52
[23]   PARKINSONS-DISEASE, MELANOMA, AND LEVODOPA [J].
FERMAGLICH, J ;
DELANEY, P .
JOURNAL OF NEUROLOGY, 1977, 215 (03) :221-224
[24]   Pharmacodynamic modelling of levodopa, 3-O-methyldopa and their effects:: An application of the Dixon equation [J].
Wu, G ;
Furlanut, M .
PHARMACOLOGICAL RESEARCH, 1999, 39 (03) :203-210
[25]   METHYLDOPA AS AN ADJUNCT TO LEVODOPA TREATMENT OF PARKINSONS DISEASE [J].
SWEET, RD ;
LEE, JE ;
MCDOWELL, FH .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1972, 13 (01) :23-+
[26]   REDUCTION OF CIRCULATING 3-O-METHYLDOPA BY INHIBITION OF CATECHOL-O-METHYLTRANSFERASE WITH OR-611 AND OR-462 IN CYNOMOLGUS MONKEYS - IMPLICATIONS FOR THE TREATMENT OF PARKINSONS-DISEASE [J].
CEDARBAUM, JM ;
LEGER, G ;
GUTTMAN, M .
CLINICAL NEUROPHARMACOLOGY, 1991, 14 (04) :330-342
[27]   3-0-METHYLDOPA AND MOTOR FLUCTUATIONS IN PARKINSONS-DISEASE [J].
FABBRINI, G ;
JUNCOS, JL ;
MOURADIAN, MM ;
SERRATI, C ;
CHASE, TN .
NEUROLOGY, 1987, 37 (05) :856-859
[28]   Pharmacokinetics of Levodopa and 3-O-Methyldopa in Parkinsonian Patients Treated with Levodopa and Ropinirole and in Patients with Motor Complications [J].
Adamiak-Giera, Urszula ;
Jawien, Wojciech ;
Pierzchlinska, Anna ;
Bialecka, Monika ;
Kobierski, Jan Dariusz ;
Janus, Tomasz ;
Gawronska-Szklarz, Barbara .
PHARMACEUTICS, 2021, 13 (09)
[29]   IDENTIFICATION OF O-METHYLDOPA IN THE VENTRICULAR FLUID OF PATIENTS WITH PARKINSONS-DISEASE [J].
IKARASHI, Y ;
MARUYAMA, Y .
BIOLOGICAL MASS SPECTROMETRY, 1992, 21 (08) :380-384
[30]   IMPAIRED LEVODOPA RESPONSE IN PARKINSONS-DISEASE DURING MELANOMA THERAPY [J].
MERELLO, M ;
ESTEGUY, M ;
PERAZZO, F ;
LEIGUARDA, R .
CLINICAL NEUROPHARMACOLOGY, 1992, 15 (01) :69-74
12345